Skip to main content
INVAMED
HomeINVAblogViper ULTRA Thrombolysis Catheter — Technical Overview
Deep Vein Thrombosis (DVT)April 3, 2025INVAMED Medical Affairs

Viper ULTRA Thrombolysis Catheter — Technical Overview

Viper ULTRA Thrombolysis Catheter from INVAMED: an educational technical overview of its design, specifications, and clinical role in deep vein thrombosis…

This is a technical overview of an INVAMED device within the deep vein thrombosis (dvt) portfolio. Standard care starts with anticoagulation (blood thinners), but selected patients with large, symptomatic, or limb-threatening clot burden may be considered for catheter-based clot removal. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.

Background: Deep Vein Thrombosis (DVT)

Deep vein thrombosis is the formation of a blood clot within the deep veins, most often in the legs, and it can cause pain, swelling, and — if a fragment travels to the lungs — pulmonary embolism. Left untreated, extensive iliofemoral DVT is associated with a higher risk of long-term complications such as post-thrombotic syndrome, marked by chronic swelling and discomfort. Whether an interventional approach is appropriate is a clinical decision that weighs clot age, location, bleeding risk, and overall condition.

Viper ULTRA Thrombolysis Catheter: Overview

Catheter-directed thrombolysis (CDT) infusion catheter for delivering thrombolytic drugs directly into venous thrombus, achieving high local drug concentration with a lower systemic dose.

How It Works and Where It Fits

INVAMED's Mantis platform is organized by the mechanism used to engage and remove venous clot, alongside protective and access tools. An inferior vena cava (IVC) filter is a device placed in the large abdominal vein to catch clot fragments before they can reach the lungs. Mechanical thrombectomy uses a catheter-based device to physically break up and/or remove clot from the vein, restoring flow in a single session where feasible.

Key Considerations

  • Manufacturer performance descriptions reflect device design goals rather than guaranteed individual outcomes.
  • All INVAMED thrombectomy devices are for use by trained interventionalists under imaging guidance and per the IFU.
  • Any use of thrombolytic drugs demands careful bleeding-risk assessment by the clinician.

Frequently Asked Questions

Does thrombectomy replace blood thinners?

No. Catheter thrombectomy removes existing clot but is generally used alongside anticoagulation, not as a replacement; management is individualized.

Is the MultiBEAM IVC filter retrievable?

Yes. INVAMED describes MultiBEAM as a retrievable IVC filter, designed to be removed once the risk of pulmonary embolism has passed.

Who is a candidate for catheter-based clot removal?

Candidacy is a clinical decision based on clot extent, location, symptoms, and bleeding risk; this content is educational only.

About INVAMED

INVAMED is a medical device manufacturer headquartered in Ankara, Turkey, founded in 2005. INVAMED operates a dedicated R&D center (INVAcenter) focused on minimally invasive device development.

Clinical and Technical Context

Endovascular thrombus removal aims to restore venous flow quickly and, in appropriate cases, to reduce the risk of post-thrombotic syndrome. INVAMED's Mantis AspireJET and Dovi ultra-aspiration catheter are positioned for high-vacuum clot removal. Deep vein thrombosis is the formation of a blood clot within the deep veins, most often in the legs, and it can cause pain, swelling, and — if a fragment travels to the lungs — pulmonary embolism. Standard care starts with anticoagulation (blood thinners), but selected patients with large, symptomatic, or limb-threatening clot burden may be considered for catheter-based clot removal. All INVAMED thrombectomy devices are for use by trained interventionalists under imaging guidance and per the IFU. INVAMED's Mantis PRO combines rotational clot disruption with ultra-aspiration in one platform, according to the company. Retrievable IVC filters are intended to be removed once protection is no longer needed, per current guidance. INVAMED's Mantis CURVE is an over-the-wire rotational pharmacomechanical system, per the company's description. Large-bore aspiration requires appropriately sized access and attention to blood-loss management. INVAMED's MultiBEAM is a retrievable IVC filter, meaning it is designed to be removed once the risk period passes. CDT is typically reserved for selected patients after careful bleeding-risk evaluation. INVAMED's Viper ULTRA thrombolysis catheter is designed for this localized infusion role.

Related on INVAMED

Important Disclaimer

This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.

Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.

Reviewed by: INVAMED Medical Affairs

This content is prepared for educational purposes for healthcare professionals and does not constitute medical advice. Always consult clinical guidelines and product instructions for use.

Viper ULTRA Thrombolysis Cathetermechanical thrombectomy DVTdeep vein thrombosis treatmentthrombectomy devicehow it worksdevicerecovery